Skip to main content
. Author manuscript; available in PMC: 2021 Nov 2.
Published in final edited form as: Mol Pharm. 2020 Oct 6;17(11):4201–4211. doi: 10.1021/acs.molpharmaceut.0c00665

Figure 5.

Figure 5.

Percent of total singlet splenocytes expressing CD11c, CD3, CD19lo, and CD19hi following in vitro incubation for 72 hours with media, 25 µM free PLP139–151, 4-arm PLP139–151, and 4-arm PLP139–151 + 25 µM free PLP139–151. Data is presented as mean ± SD. N=3, * represents significance from 25 µM free PLP139–151. # represents significance from Media.